T1	HMM 0 21	Histologic conversion
T2	HMM 698 725	complete response rate (CR)
T3	HMM 754 767	achieved a CR
T4	HMM 779 788	relapsed.
T5	HMM 833 845	achieve a CR
T6	HMM 849 862	achieved a CR
T7	HMM 873 882	relapsed.
T8	HMM 883 904	Histologic conversion
T9	HMM 1044 1073	actuarial risk for conversion
T10	HMM 1092 1099	greater
T11	HMM 1119 1161	median time to documentation of conversion
T12	HMM 1177 1188	most common
T13	HMM 1197 1218	histologic conversion
T14	HMM 1244 1265	histiocytic lymphoma.
T15	HMM 1277 1298	histologic conversion
T16	HMM 1332 1360	aggressive clinical behavior
T17	HMM 1386 1401	median survival
T18	HMM 1408 1418	conversion
T19	HMM 1467 1480	achieved a CR
T20	HMM 1487 1497	conversion
T21	HMM 1509 1546	favorable outcome (actuarial survival
T22	HMM 1573 1585	risk factors
T23	HMM 1600 1621	histologic conversion
